Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence

ClinicalTrials.gov ID: NCT03052764

Public ClinicalTrials.gov record NCT03052764. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 3:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence (LO-BOT)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the efficacy and safety of onabotulinumtoxinA 100 U (BOTOX®), compared to placebo, when injected into the bladder using an alternative injection paradigm in reducing the number of daily urinary incontinence episodes in patients with overactive bladder (OAB) and urinary incontinence whose symptoms have not been adequately managed with an anticholinergic.

Study identification

NCT ID
NCT03052764
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Allergan
Industry
Enrollment
120 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 12, 2016 (Actual)
Primary completion
Dec 10, 2018 (Actual)
Completion
Dec 10, 2018 (Actual)
Last update posted
Dec 24, 2019

2016 – 2018

United States locations

U.S. sites
31
U.S. states
18
U.S. cities
30
Facility City State ZIP Site status
Orange County Urology Associates Laguna Hills California 92653 —
Tower Urology Los Angeles California 90048 —
University of California, Irvine Medical Center Orange California 92868 —
Genitourinary Surgical Consultants Denver Colorado 80220 —
East Coast Institute for Research, LLC Jacksonville Florida 32204 —
PMG Research of Christie Clinic Champaign Illinois 81820 —
Deaconess Clinic, Inc. Evansville Indiana 47113 —
Women's Health Advantage Fort Wayne Indiana 46825 —
Urogynecology Associates Indianapolis Indiana 46062 —
Urology of Indiana Noblesville Indiana 46062 —
Iowa Clinic West Des Moines Iowa 50266 —
Regional Urology Shreveport Louisiana 71106 —
Chesapeake Urology Owings Mills Maryland 21117 —
Beyer Research Kalamazoo Michigan 49009 —
Michigan Institute of Urology, P.C. Troy Michigan 48084 —
Adult and Pediatric Urology Omaha Nebraska 68114 —
Premier Urology LLC Edison New Jersey 08837 —
Western New York Urology Associates Cheektowaga New York 14225 —
Manhattan Medical Research New York New York 10016 —
Advanced Urology Centers of NY A division of IMP Plainview New York 11803 —
Premier Medical Group of the Hudson Valley Poughkeepsie New York 12601 —
Alliance Urology Specialists Greensboro North Carolina 27403 —
Sandhills Medical Center Hamlet North Carolina 28345 —
PMG Research of Wilmington Wilmington North Carolina 28401 —
Urologic Consultants of Southeastern Pennsylvania Bala-Cynwyd Pennsylvania 19004 —
Center for Pelvic Health Franklin Tennessee 37067 —
Urology Clinics of North Texas Dallas Texas 75231 —
Virginia Urology Richmond Virginia 23230 —
Virginia Urology Center Richmond Virginia 23235 —
Urology of Virginia Virginia Beach Virginia 23462 —
Integrity Medical Research, LLC Mountlake Terrace Washington 98043 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03052764, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 24, 2019 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03052764 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →